L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin.
about
Hepatocellular carcinoma and the risk of occupational exposureSingle-Incision Laparoscopic Cholecystectomy: our experience and review of literatureChronic hepatitis C: This and the new era of treatmentAntiviral treatment of hepatitis C virus infection and factors affecting efficacyThrombocytopenia in Patients with Chronic Hepatitis C Virus InfectionAcetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical TrialCurrent experience in testing mitochondrial nutrients in disorders featuring oxidative stress and mitochondrial dysfunction: rational design of chemoprevention trials.L-carnitine supplementation in patients with HIV/AIDS and fatigue: a double-blind, placebo-controlled pilot study.Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety and increases work ability.Effects of Oral L-Carnitine on Liver Functions after Transarterial Chemoembolization in Intermediate-Stage HCC Patients.Efficacy and safety of entecavir plus carnitine complex (GODEX®) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL study.Acetyl-L-carnitine in hepatic encephalopathy.The immune system in hepatocellular carcinoma and potential new immunotherapeutic strategies.Silybin-vitamin E-phospholipids complex reduces liver fibrosis in patients with chronic hepatitis C treated with pegylated interferon α and ribavirin.Effect of L-Carnitine in Patients With Liver Cirrhosis on Energy Metabolism Using Indirect Calorimetry: A Pilot Study.Carnitine deficiency and its possible risk factors in TB patients: first report.Anorectal mucosal melanoma.Carcinoembryonic Antigen Serum Levels in Nonmelanoma Skin Cancer.Resveratrol in Patients with Minimal Hepatic Encephalopathy.
P2860
Q26750646-C9A022B1-AEFA-4258-B8BC-4D7FA5EA3D1AQ26765065-70017E30-E217-4346-B9DF-2DBC3B56E20FQ26775011-56617069-3EAE-4CFD-B351-1E56F66F4C39Q26851810-904734C4-9CBD-4328-9EF2-C0FBE6C8DC84Q33440130-E886E67B-5A96-488A-8770-B22963B590FAQ33647262-2322F2EE-476A-4020-8EF7-6096F530AB76Q34685307-AF937AB2-C30F-4DA5-A454-0B87198AE3BAQ35121171-B2AEAB2C-D0A7-43C1-81BA-702A683D1B43Q36192046-36C8241A-64BC-4BC7-B27F-038B241EA44BQ36343125-DEB0F439-9B0F-4D47-BC00-60C045639623Q36983539-B858FEB3-889D-4372-8B54-63DDA2BDD038Q38079759-B1B2525B-3884-420B-991B-9A0E4BFE5A53Q39535683-7F37AB09-67C6-40AD-AAEE-B57E23F41ED8Q41426862-2C93A8A3-8D8B-460C-8ED0-E7E897AEB714Q41627214-F36E3B41-5799-4BF4-9CB2-78614B62FCF2Q42249006-31CD8A24-49CF-4798-BCAC-EF697442217FQ52680468-F5E3FAC4-CAE3-4B1B-927A-0EE20914474DQ52688594-D8E4482C-2577-4783-A509-C0F329423DD1Q53438002-01184F46-9B7A-4AA2-8818-559D99FAA35F
P2860
L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
L-carnitine supplementation im ...... nterferon-α 2b plus ribavirin.
@ast
L-carnitine supplementation im ...... nterferon-α 2b plus ribavirin.
@en
type
label
L-carnitine supplementation im ...... nterferon-α 2b plus ribavirin.
@ast
L-carnitine supplementation im ...... nterferon-α 2b plus ribavirin.
@en
prefLabel
L-carnitine supplementation im ...... nterferon-α 2b plus ribavirin.
@ast
L-carnitine supplementation im ...... nterferon-α 2b plus ribavirin.
@en
P2093
P2860
P50
P356
P1476
L-carnitine supplementation im ...... nterferon-α 2b plus ribavirin.
@en
P2093
Giovanni Li Volti
Manuela Pennisi
Marco Vacante
Maria Giordano
Massimo Motta
Michele Malaguarnera
P2860
P304
P356
10.3748/WJG.V17.I39.4414
P407
P577
2011-10-01T00:00:00Z